INS and metabolic syndrome: Under pathological conditions such as metabolic syndrome, these normal effects of insulin are perturbed, leading to abnormal adipogenesis as characterized by lack of differentiation in adipocyte precursors (pre-adipocytes), increased inflammation in such cells and higher levels of circulating lipids in the bloodstream [18–21].